Page last updated: 2024-11-02

palmidrol and Glial Cell Tumors

palmidrol has been researched along with Glial Cell Tumors in 2 studies

palmidrol: a cannabinoid receptor-inactive eCB-related molecule used as prophylactic in helping to prevent respiratory viral infection
palmitoyl ethanolamide : An N-(long-chain-acyl)ethanolamine that is the ethanolamide of palmitic (hexadecanoic) acid.

Research Excerpts

ExcerptRelevanceReference
" 19 and 20 produced leftward shifts in the dose-response curve for AEA activation of Ca(2+) influx into hVR1-HEK293 cells."1.32N-Morpholino- and N-diethyl-analogues of palmitoylethanolamide increase the sensitivity of transfected human vanilloid receptors to activation by anandamide without affecting fatty acid amidohydrolase activity. ( Fowler, CJ; Jonsson, KO; Lambert, DM; Smart, D; Vandevoorde, S, 2003)

Research

Studies (2)

TimeframeStudies, this research(%)All Research%
pre-19900 (0.00)18.7374
1990's0 (0.00)18.2507
2000's1 (50.00)29.6817
2010's1 (50.00)24.3611
2020's0 (0.00)2.80

Authors

AuthorsStudies
Raso, GM1
Esposito, E1
Vitiello, S1
Iacono, A1
Santoro, A1
D'Agostino, G1
Sasso, O1
Russo, R1
Piazza, PV1
Calignano, A1
Meli, R1
Vandevoorde, S1
Lambert, DM1
Smart, D1
Jonsson, KO1
Fowler, CJ1

Other Studies

2 other studies available for palmidrol and Glial Cell Tumors

ArticleYear
Palmitoylethanolamide stimulation induces allopregnanolone synthesis in C6 Cells and primary astrocytes: involvement of peroxisome-proliferator activated receptor-α.
    Journal of neuroendocrinology, 2011, Volume: 23, Issue:7

    Topics: Amides; Animals; Animals, Newborn; Astrocytes; Brain Neoplasms; Cell Culture Techniques; Cell Line,

2011
N-Morpholino- and N-diethyl-analogues of palmitoylethanolamide increase the sensitivity of transfected human vanilloid receptors to activation by anandamide without affecting fatty acid amidohydrolase activity.
    Bioorganic & medicinal chemistry, 2003, Mar-20, Volume: 11, Issue:6

    Topics: Amides; Amidohydrolases; Animals; Arachidonic Acids; Brain Neoplasms; Calcium Channel Blockers; Caps

2003